Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
SHPH - Shuttle Pharmaceuticals Holding
Market Cap 12.43M P/E - EPS this Y - Ern Qtrly Grth -
Income -6.59M Forward P/E - EPS next Y - 50D Avg Chg -16.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg -46.00%
Dividend N/A Price/Book 1.78 EPS next 5Y - 52W High Chg -99.00%
Recommedations - Quick Ratio 5.26 Shares Outstanding 16.89M 52W Low Chg 8.00%
Insider Own 45.11% ROA -50.43% Shares Float 9.55M Beta -
Inst Own 2.12% ROE -112.37% Shares Shorted/Prior 65.58K/51.35K Price 0.90
Gross Margin - Profit Margin - Avg. Volume 1,508,429 Target Price -
Oper. Margin - Earnings Date - Volume 66,192 Change -1.09%
Healthcare | Drug Manufacturers - Specialty & Generic | United States
About Shuttle Pharmaceuticals Holding

Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to cure cancers. It develops Ropidoxuridine, an oral halogenated pyrimidine to treat patients with brain tumors and sarcomas, SP-1-161, an HDAC inhibitor that initiates the mutated in ataxia-telangiectasia response pathway for radiation sensitizing cancer cells and protecting normal cells; SP-2-225, a pre-clinical class IIb that effects on the regulation of the immune system; and SP-1-303, a pre-clinical selective Class I HDAC for the treatment of ER positive cancers. The company was founded in 2012 and is based in Rockville, Maryland.

Shuttle Pharmaceuticals Holding News
04/03/24 Shuttle Pharmaceuticals to Present at the Emerging Growth Conference on April 4, 2024
04/03/24 Presenting on the Emerging Growth Conference 69 Day 2 on April 4 Register Now
03/22/24 Shuttle Pharma Provides Fourth Quarter 2023 Corporate Update
03/05/24 Shuttle Pharmaceuticals to Present at the Emerging Growth Conference on March 6, 2024
03/05/24 Presenting on the Emerging Growth Conference 68 Day 1 on March 6 Register Now
02/13/24 Shuttle Pharma Announces Its Intent to Pursue a Rights Offering
01/23/24 Shuttle Pharma to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference on February 1, 2024
01/08/24 Shuttle Pharmaceuticals Receives FDA Approval to Proceed with Phase II Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma
12/11/23 Shuttle Pharmaceuticals Submits IND Application to the U.S. FDA for Ropidoxuridine Phase II Clinical Trial for Patients with Glioblastoma
12/06/23 Presenting on the Emerging Growth Conference 65 Day 2 on December 7th Register Now
11/30/23 Shuttle Pharmaceuticals to Present at the Emerging Growth Conference on December 7, 2023
11/14/23 Shuttle Pharmaceuticals Provides Third Quarter 2023 Corporate Update
10/31/23 Shuttle Pharma Advances Prostate Cancer Predictive Biomarker Program Through Exclusive License Agreement
10/10/23 Shuttle Pharma to Participate in the Lytham Partners Fall 2023 Investor Conference
09/25/23 Shuttle Pharma Announces Results of Pre-IND Meeting with FDA for Ropidoxuridine Phase II Clinical Trial for Patients with Glioblastoma
09/13/23 Shuttle Pharma Participates in Hampton University Proton Therapy Institute Prostate Cancer & Men's Health Fair
09/11/23 Shuttle Pharma Expands Patent Coverage on HDAC Inhibitor Platform
08/29/23 Shuttle Pharma's Selective HDAC6 Inhibitor Shown to Stimulate Innate Immune Response in Pre-clinical Studies, as Reported in Molecular Cancer Therapeutics
08/15/23 Shuttle Pharmaceuticals Provides Second Quarter 2023 Corporate Update
08/03/23 Shuttle Pharmaceuticals Completes Manufacturing of Active Pharmaceutical Ingredient (API) for Use in Clinical Trial
SHPH Chatroom

User Image DonCorleone77 Posted - 1 week ago

$SHPH Shuttle Pharmaceuticals files to sell subscription rights to buy $4.5M in units Boustead Securities is placement agent.

User Image RollingDollar Posted - 2 weeks ago

$SHPH

User Image Stock_Titan Posted - 2 weeks ago

$SHPH Shuttle Pharmaceuticals to Present at the Emerging Growth Conference on April 4, 2024 https://www.stocktitan.net/news/SHPH/shuttle-pharmaceuticals-to-present-at-the-emerging-growth-conference-z08jknnzx3fk.html

User Image STINKINSTONK Posted - 03/26/24

$SHPH nice cup and handle coming to completion . This will run soon 😎

User Image hooks2 Posted - 03/22/24

$SHPH I think they need a cheerleader or hire new PR agency.

User Image hooks2 Posted - 03/22/24

$SHPH Good news after good news and this stock is dead.

User Image Stock_Titan Posted - 03/22/24

$SHPH Shuttle Pharma Provides Fourth Quarter 2023 Corporate Update https://www.stocktitan.net/news/SHPH/shuttle-pharma-provides-fourth-quarter-2023-corporate-weps6mhrz7dd.html

User Image GATORSFL Posted - 4 weeks ago

$HPCO First of many. $TLRY $CGC $ACB $SHPH

User Image PatentGrants Posted - 1 month ago

$SHPH Shuttle Pharmaceuticals has been granted European patent number EP3737376 titled "SELECTIVE HISTONE DEACETYLASE INHIBITORS FOR THE TREATMENT OF HUMAN DISEASES (INCLUDING CANCERS, NEUROLOGICAL DISORDERS, AND IMMUNOLOGICAL DISORDERS)". https://register.epo.org/application?number=EP19738394

User Image NotHopeJustFacts Posted - 1 month ago

$SHPH please when is the RS ? and the next one ? LOL

User Image MyTradeReliance Posted - 1 month ago

$SHPH wants to go up. PT 1x.

User Image Stock_Titan Posted - 1 month ago

$SHPH Shuttle Pharmaceuticals to Present at the Emerging Growth Conference on March 6, 2024 https://www.stocktitan.net/news/SHPH/shuttle-pharmaceuticals-to-present-at-the-emerging-growth-conference-oj11bu0mioss.html

User Image Mgirardi2000 Posted - 1 month ago

$SHPH this ever had volumn like the Asian stocks of TOP it would explode to $40 plus. Easy pump stock and easy money if trended here and Reddit

User Image BallsOfSteel7 Posted - 02/26/24

$SHPH on watch 👀

User Image NotHopeJustFacts Posted - 2 months ago

$SHPH I thought this was already been delisted

User Image Charliemuscle Posted - 2 months ago

$SHPH https://www.tipranks.com/news/company-announcements/shuttle-pharmaceuticals-advances-prostate-cancer-diagnostics-funding

User Image Stock_Titan Posted - 2 months ago

$SHPH Shuttle Pharma Announces Its Intent to Pursue a Rights Offering https://www.stocktitan.net/news/SHPH/shuttle-pharma-announces-its-intent-to-pursue-a-rights-75voclmctp86.html

User Image Vulture14 Posted - 2 months ago

$SHPH🙏🙏

User Image Vulture14 Posted - 2 months ago

$SHPH what do they know

User Image Vulture14 Posted - 2 months ago

$SHPH lets see 🤑

User Image Vulture14 Posted - 2 months ago

$SHPH it moves so easy up with the smallest amount of volume.but yet keeps going down slowly Day after day 😑

User Image Vulture14 Posted - 2 months ago

$SHPH fml🤷‍♂️😱

User Image Vulture14 Posted - 2 months ago

$SHPH anyone still here and is there any hope?

User Image Vulture14 Posted - 2 months ago

$SHPH

User Image monkeyhustle55 Posted - 01/27/24

$SHPH Did SHPH reverse split yet?

User Image Mgirardi2000 Posted - 01/26/24

$SHPH where are the lawsuits or attorneys asking to file claims?

User Image TheGodofthestocksmarket8 Posted - 01/25/24

$SHPH

User Image Vulture14 Posted - 01/25/24

$SHPH

User Image Vulture14 Posted - 01/25/24

$SHPH up please☝️

User Image Vulture14 Posted - 01/24/24

$SHPH is this ever going to run again??

Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Brown Milton Director Director Dec 13 Sell 0.4632 2,921 1,353 1,094,610 01/02/24
Jacobs Bette Director Director Dec 13 Sell 0.4632 4,157 1,926 27,064 12/20/23
Dritschilo Anatoly CEO and Chairman CEO and Chairman Dec 29 Sell 1.605 8,372 13,437 1,085,200 01/03/23
Rich Tyvin Chief Medical Office.. Chief Medical Officer Dec 29 Sell 1.605 1,414 2,269 2,429 01/03/23
Jung Mira Chief Scientific Off.. Chief Scientific Officer Dec 29 Sell 1.605 328 526 1,071,388 01/03/23
Jacobs Bette Director Director Dec 29 Sell 1.605 4,366 7,007 31,221 01/03/23
Dritschilo Peter President and COO President and COO Dec 29 Sell 1.605 3,820 6,131 6,560 12/30/22